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Abstract
Compartmentalized HIV-1 replication within the central nervous system (CNS) likely pro-
vides a foundation for neurocognitive impairment and a potentially important tissue reser-
voir. The timing of emergence and character of this local CNS replication has not been
defined in a population of subjects. We examined the frequency of elevated cerebrospinal
fluid (CSF) HIV-1 RNA concentration, the nature of CSF viral populations compared to the
blood, and the presence of a cellular inflammatory response (with the potential to bring in-
fected cells into the CNS) using paired CSF and blood samples obtained over the first two
years of infection from 72 ART-naïve subjects. Using single genome amplification (SGA)
and phylodynamics analysis of full-length env sequences, we compared CSF and blood
viral populations in 33 of the 72 subjects. Independent HIV-1 replication in the CNS
(compartmentalization) was detected in 20% of sample pairs analyzed by SGA, or 7% of all
sample pairs, and was exclusively observed after four months of infection. In subjects with
longitudinal sampling, 30% showed evidence of CNS viral replication or pleocytosis/inflam-
mation in at least one time point, and in approximately 16% of subjects we observed evolv-
ing CSF/CNS compartmentalized viral replication and/or a marked CSF inflammatory
response at multiple time points suggesting an ongoing or recurrent impact of the infection
in the CNS. Two subjects had one of two transmitted lineages (or their recombinant) largely
sequestered within the CNS shortly after transmission, indicating an additional mechanism
for establishing early CNS replication. Transmitted variants were R5 T cell-tropic. Overall,
examination of the relationships between CSF viral populations, blood and CSF HIV-1 RNA
concentrations, and inflammatory responses suggested four distinct states of viral popula-
tion dynamics, with associated mechanisms of local viral replication and the early influx of
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virus into the CNS. This study considerably enhances the generalizability of our results and
greatly expands our knowledge of the early interactions of HIV-1 in the CNS.
Author Summary
Early HIV-1 CNS replication likely provides a foundation for brain injury and a potentially
important tissue reservoir. To explore the character and timing of emergence of early HIV-1
CNS replication, we examined paired cerebrospinal fluid (CSF) and blood samples from 72
ART-naïve adults, with one-half having longitudinal samples, during the first two years fol-
lowing HIV-1 subtype B infection. In a cross sectional analysis over the first two years of in-
fection, 10–25% of subjects had evidence of either local viral replication in the CNS, defined
by the presence of CSF compartmentalization, or a robust inflammatory response, and in ap-
proximately 16% of subjects this CNS involvement persisted over time. In some subjects,
one of two transmitted viruses replicated predominantly within the CNS, providing insight
into how HIV-1 can establish independently replicating populations early in different parts
of the body. Based on their entry phenotype, all viruses were selected for replication in CD4+
T cells, although this phenotype was slightly altered in the compartmentalized virus. Overall,
we suggest four states to model the nature of HIV-1 CNS infection, which imply distinct
mechanisms of virus/host interaction within the CNS during early infection.
Introduction
While HIV-1 can be detected in both the cerebrospinal fluid (CSF) and brain tissue during the
weeks after initial exposure [1–7], it is unknown when the virus actually begins replicating in-
dependently in the central nervous system (CNS). Independent viral replication within the
CNS has two important implications. First, HIV-1 replication can lead to CNS dysfunction and
injury, and while combination antiretroviral therapy (cART) has markedly reduced the inci-
dence of HIV-associated dementia (HAD), the prevalence of milder HIV-associated neurologi-
cal disorders (HAND) has increased [8,9] in the cART era. Second, independent CNS
replication may also provide a reservoir distinct from that found in CD4+ T cells in the blood
and lymphoid tissue. We do not know the time course of the virologic events that lead to neu-
rological dysfunction and the potential establishment of a CNS reservoir, or the extent to
which these long-term outcomes are predicted by the initial aspects of virus-host interaction.
While extensive independent, or compartmentalized, CSF/CNS replication is associated
with severe HIV-1 clinical CNS dysfunction [1,10–13], genetically distinct virus can be de-
tected in the CNS throughout the course of infection [4,10]. Thus far, two types of compart-
mentalization have been defined: one in which a few variants are rapidly expanded giving a
CSF viral population of low complexity (clonal amplification) consisting of variants that re-
quire high levels of CD4 for entry (R5 T cell-tropic). The second type is characterized by a
complex CSF viral population consisting of variants that can enter cells expressing low levels of
CD4 (macrophage-tropic), indicative of a more prolonged period of isolated replication and
evolution of the entry phenotype. Additionally, we have recently shown that after vertical
transmission to children, CNS compartmentalization can be established via two mechanisms:
the early sequestration of one of multiple transmitted variants in the CNS, or the later estab-
lishment of compartmentalized CNS virus originating from the periphery [14]. In a previous
study, we demonstrated CSF HIV-1 compartmentalization in human subjects during the first
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PLOS Pathogens | DOI:10.1371/journal.ppat.1004720 March 26, 2015 2 / 24
Competing Interests: The authors have declared
that no competing interests exist.
year of HIV-1 infection in adults [4]. However, that study only examined viral population se-
quences from CSF and plasma in a small number of subjects (eight), limiting the generalizabili-
ty of our findings. Furthermore, the previous study had sparse assessment of longitudinal
samples, and included no analysis of sources of compartmentalized HIV-1 within the CSF.
For the current study, we used single genome amplification (SGA) and phylogenetic analysis to
assess viral populations in the CSF in the presence and absence of cellular inflammation (i.e. pleo-
cytosis) in cross-sectional and often longitudinal paired blood plasma and CSF samples obtained
during the first two years of HIV-infection in ART-naïve subjects. We also extended our analytical
approach to include Bayesian Evolutionary Analysis by Sampling Trees (BEAST) to assess time to
most recent common ancestor (TMRCA) of CSF and blood HIV-1 populations [15], providing
new insights on the timing of establishment of early compartmentalized populations, and we as-
sessed the entry phenotypes of selected clones, further confirming the nature of the transmitted
virus as R5 T cell-tropic [16]. Based upon a complex interplay between HIV-1 RNA concentration,
viral compartmentalization, and CSF white blood cell (WBC) count, we suggest at least four differ-
ent patterns to characterize the relationship between virus in the blood and virus in the CSF/CNS
during the early period after infection. The current study considerably enhances the generalizability
of our results and provides an unprecedented view of the early interactions of HIV-1 in the CNS.
Results
Study population and analysis parameters
We analyzed the HIV-1 RNA concentrations in paired blood plasma and CSF samples collect-
ed from 72 adult subjects enrolled in an observational neurological study of primary HIV-1 in-
fection, defined as within one year of initial infection. All subjects were infected with HIV-1
subtype B and were ART-naïve at all study intervals, except for one subject, 9018, who was
treated with tenofovir, emtricitabine, and atazanavir between the first and second analyzed
time points. Paired follow-up samples were assessed for 37 subjects with longitudinal samples
available within the initial two years post infection (p.i.). In total, 144 paired samples were
available for analysis. Baseline demographic and clinical characteristics at enrollment for the
entire cohort (n = 72) and for the subset that had sufficient CSF viral RNA concentrations
(defined as greater than 1,000 copies of viral RNA/ml) to allow adequate sampling of the
viral population via SGA (n = 33) are shown in Table 1. For the 33 subjects whose samples
were analyzed by SGA, a total of 55 blood plasma/CSF sample pairs were analyzed including
the longitudinal samples (Table 2; three time points for subject 9018 and one time point for
Table 1. Background demographic and clinical characteristics of study participants at baseline.
Entire PHI cohort (n = 72) Subjects analyzed by SGA (n = 33)a
Sex, % male 98.6 97.0
Age (years) 36 (28–43) 36 (31–44)
Days post infection 106 (73–158) 128 (76–173)
CD4+ T cells (cells/μl) 567 (411–732) 488 (361–714)
plasma HIV-1 RNA (log10 copies/ml) 4.66 (4.09–5.08) 5.06 (4.72–5.58)
CSF HIV-1 RNA (log10 copies/ml) 2.62 (1.74–3.32) 3.37 (2.97–3.82)
CSF WBC (cells/μl) 6.0 (3.0–10.8) 7.0 (4.0–12.0)
CSF/plasma albumin ratio 5.0 (4.0–6.8) 5.2 (3.7–6.8)
Values shown are medians (interquartile ranges) except where noted
aSubjects with sufficient viral RNA loads in the CSF (>1,000 copies of viral RNA/ml; to ensure adequate
sampling) for further SGA analysis at one or more time points within the first two years.
doi:10.1371/journal.ppat.1004720.t001
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P Value P Value P Value
7146 156 5.63 5.23 552 86 14.35 0.021 0.013 0.005 Cp, Ap 965* 85
177 5.34 4.4 476 97 14.35 0.1599 0.0157 0.313 Eq
203 5.01 4.41 310 53 7.12 0.0058 <0.0001 <0.0001 Cp, Ap
9001 308 5.29 3.07 573 4 3.5 0.4296 0.05658 0.2458 Eq 378
399 4.87 3.61 575 5 4.33 0.83 0.1454 0.1252 Eq 456
9002 275 4.65 3.66 539 8 7.35 0.59 0.1843 0.1346 Eq 296 43
338 4.57 4.08 501 14 9.61 0.3192 0.0334 0.666 Eq, Ap 309 76
9003 375 4.56 3.18 521 4 3.19 0.8633 0.8188 0.3676 Eq 1292*
9006 153 4.44 3.11 435 8 4.64 0.5726 0.4418 0.2694 Eq 167
340 4.82 3.21 453 6 3.75 0.8377 0.487 0.3086 Eq 493
9007 149 5.37 2.63 256 4 10.85 0.6991 0.0946 0.5982 Eq 307
406 4.47 3.59 292 4 6.87 0.1191 0.0614 0.0036 Eq 231 117
9015 77 5.41 3.33 474 6 7.4 0.6269 0.7226 0.811 Eq 153
9016 409 5.06 3.38 344 0 4.2 0.4389 0.4254 0.388 Eq 390
691 4.94 3.12 237 5 4.3 0.5313 0.3026 0.322 Eq 592
9018 200 5.61 4.57 350 11 6.45 0.2295 0.0008 0.1166 Eq, Ap 2277* 140
687 4.8 4.47 491 119l 9.29 0.4681 0.5672 0.2728 Eq
876 4.65 4.55 425 71 11.84 0.3772 0.1312 0.2978 Eq
1073 4.95 3.99 453 14 7.97 0.0631 0.0026 0.0456 Eq, Ap
1180 4.98 4.61 505 17 5.34 <0.0001 <0.0001 <0.0001 Cp, Ap
9019 100 4.69 3.14 750 13 5.58 0.0956 0.6085 0.0026 Eq 82
9020 240 4.59 3.45 368 10 6.95 0.0049 0.0076 0.0024 Cp 608* 246
9021 140 4.82 3.37 441 8 4.89 0.0017 0.0008 0.0068 Cp, Ap 159 102
341 5.8 4.01 446 71 5.21 0.0021 <0.0001 0.0006 Cp, Ap 314 55
9024 222 4.75 4.29 974 12 5.74 0.913 0.2318 0.0412 Eq 196
405 4.63 3.73 732 5 4.34 0.6906 0.3016 0.3252 Eq 379
596 4.4 4.01 600 10 5.58 0.7406 0.2084 0.5158 Eq 1045
9025 50 5 4.18 752 7 3.91 0.0743 0.3496 0.098 Eq 49
9027 234 4.84 3 402 6 6.17 0.3348 0.134 0.7062 Eq 236 115
425 4.76 3.39 375 5 6.11 0.9693 0.984 0.6206 Eq 775
9036 223 4.48 3.11 610 4 6.07 0.3106 0.5858 0.0552 Eq 386
9037 46 5.71 3.43 884 26 6.35 0.4384 0.1944 0.4818 Eq 52
9039 36 5.57 4.3 539 53 9.31 0.4768 0.0136 0.4114 Eq 89
9040 165 4.22 3.79 705 4 7.67 <0.0001 <0.0001 <0.0001 Cp, Ap 209 33
352 4.88 3.15 664 3 9.19 <0.0001 <0.0001 <0.0001 Cp, Ap 262 131
644 5.34 3.64 484 2 8.15 0.002 0.0006 <0.0001 Cp 553 321
918 5.44 3.37 279 4 8.33 0.3973 0.0546 0.324 Eq
9044 128 4.82 3.49 533 20 4.3 0.4608 0.0482 0.199 Eq, Ap 124 50
190 5.08 3.98 583 30 4.01 0.7711 0.6476 0.2786 Eq, Ap 307
9045 54 4.75 3.1 542 9 4.46 0.2913 0.36 0.125 Eq, Ap 214
9048 58 5.21 3.1 456 11 7.52 0.4808 0.6226 0.3934 Eq 131 73
9055 106 5.38 3.51 619 12 6.42 0.0239 0.0576 0.2396 Eq 83
9058 110 5.18 3.66 237 4 2.44 0.2438 0.4112 0.1512 Eq 398
(Continued)
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subject 9040 beyond 2 years p.i. were analyzed but were not included in any overall population
analysis.)
Following SGA and phylogenetic analysis, compartmentalization was assessed by three ap-
proaches. The choice to use multiple approaches was based on the recent findings of Zarate et al.
[17] illustrating that different methods of assessing compartmentalization often yield divergent re-
sults. Thus, we assessed CNS compartmentalization using three methods—the tree-based Slatkin-
Maddison test (SM) [18] and two distance-based methods, Wright’s measure of population subdi-
vision (Fst) [19,20] and the Nearest-neighbor statistic (Snn) [21]. CNS lineages were interpreted as
being significantly compartmentalized if all three tests were significant (P values< 0.05). We define
CNS phylogenetic states as (Fig. 1): i) equilibrated, with similar populations between the blood and
























P Value P Value P Value
9062 103 4.88 3.43 420 16 4.09 0.4486 0.9792 0.462 Eq 89
9063 86 5.06 3.01 558 4 3.38 0.3342 0.3428 0.5326 Eq 565*
9071 128 5.59 3.93 279 6 4.31 0.8112 0.6726 0.7572 Eq 124
177 5.64 4.08 468 13 4.3 0.9343 0.828 0.9708 Eq 147
9073 75 5.68 4.01 297 42 2.07 0.9946 0.9484 0.9906 Eq 765*
9076 185 5.66 3.85 111 4 4.09 0.9866 0.597 0.931 Eq 257
9082 106 4.9 3.94 421 32 2.14 0.99329 0.316 0.4412 Eq 91
9083 151 5.37 3.72 352 7 3.55 0.9428 0.6502 0.2848 Eq 374
344 5.31 3.55 389 3 5.48 0.1948 0.2918 0.7494 Eq 754
9096 271 5.58 3.77 666 3 2.68 0.0915 0.0376 0.008 Eq 649 253
348 4.39 3.53 743 9 3.02 <0.0001 <0.0001 <0.0001 Cp, Ap 707 337
9097 55 4.9 3.29 802 8 11.95 0.0163 0.0016 0.0394 Eqm 63
aTime point(s) beyond 2 years p.i. analyzed for subject 9018 and 9040 were not included in any overall population analyses.
bEstimated.
c,dVL, viral load; HIV-1 RNA (log10 copies/ml).
eCells/μl.
fCSF white blood cell (WBC) count, cell/μl.
gCSF/plasma albumin ratio.
hThree statistical analyses of genetic compartmentalization between viral populations in the blood plasma and CSF: Slatkin-Maddison test (SM) [18],
Wright’s measure of population subdivision (Fst) [19,20] and the Nearest-neighbor statistic (Snn) [21]. P values <0.05 indicated statistically significant
genetic compartmentalization.
iHIV-1 population characteristics in the CSF compartment (compart). Eq, equilibrated blood plasma and CSF populations; Cp (compartmentalized),
significant compartmentalization by three compartmentalization analyses; Ap, clonal amplification of 3 variants detected in the CSF.[18]
jTMRCA (Time to Most Recent Common Ancestor) of the entire viral population, analyzed by BEAST [15]. An asterisk (*) indicates transmission of >
1 variant.
kTMRCA for the compartmentalized (Comp) CSF population for compartmentalized subjects.
lPatient 9018 diagnosed with neurosyphilis at indicated date.
mSignificant compartmentalization scores were due to a compartmentalized lineage in the plasma. After removing this plasma lineage, the remaining
plasma and CSF sequences were equilibrated.
doi:10.1371/journal.ppat.1004720.t002
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genetically distinct CSF population as indicated by three statistically significant measures of
compartmentalization (Fig. 1B). In our analyses, compartmentalized populations typically included
clonally amplified variants often with more genetically diverse variants (Fig. 1B, Sub. 9040), and
sometimes with the presence of recombinants between two clonally amplified variants (Fig. 1B, Sub.
9096). In order to determine how often our statistical assessment of CNS compartmentalization
was due to the presence of clonally amplified viruses, we performed additional analyses in which
we collapsed clonally amplified sequences into a single sequence and repeated the tests of compart-
mentalization. We determined that of the eight sample pairs that displayed both clonal amplifica-
tion and CNS compartmentalization, three were significantly compartmentalized after collapsing
the clonal sequences. This suggests that clonal amplification may drive the statistical assessment of
compartmentalization or may be a symptom of ongoing CNS replication. Under this latter scenar-
io, we propose that ongoing viral replication in the CNS may produce diverse, CNS-specific line-
ages and trigger an influx of T cells that amplify some of these lineages. Table 2 shows the clinical
and virologic assessment for each subject who had at least one time point analyzed by SGA, and
S1 Table shows this information for the 39 subjects who had no time points analyzed by SGA.
We also considered what role cellular inflammation (pleocytosis) might play in determining
both the HIV-1 RNA concentrations and the nature of the viral population in the CSF, specifi-
cally whether an equilibrated population might exist with higher CSF HIV-1 RNA concentra-
tions due to an influx of cells, including infected cells, during an inflammatory response. For
our analyses, we chose a cut-off of 10 WBC/μl to define a state of CSF pleocytosis, as this is
two-times the published upper limit of normal values of CSF WBC (5 cells/μl) [22] ensuring
that the measured pleocytosis was a robust marker for an inflammatory response.
Fig 1. HIV-1 blood and CSF populations early during infection can be equilibrated or
compartmentalized.Neighbor-joining phylogenetic trees depicting sequence relationships from subjects
with (A) equilibrated and (B) compartmentalized viral populations. env sequences from the CSF (blue circles)
and blood plasma (red triangles) are shown. Bootstrap values35 are included (*) at the appropriate nodes.
Genetic distance is indicated at the bottom of each figure (0.001, number of nucleotide substitutions per site
between env sequences). Compartmentalized CNS populations are designated by an open circle at the
appropriate node and a solid blue bracket. Clonal amplification is indicated by a solid black bar.
doi:10.1371/journal.ppat.1004720.g001
CNS HIV-1 Replication during Early Infection
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Approximately two-thirds of subjects have low CSF viral RNA
concentrations during the first two years of infection
In order to assess temporal patterns of CNS viral replication and inflammation, we treated all
144 paired samples from the 72 subjects as independent observations (a limitation of the analy-
sis but one that allowed us to categorize the samples by time post infection). We divided the
samples into the following three windows: acute, 0–4 months p.i.; early, 5–12 months p.i.; or es-
tablished, 13–24 months p.i.. The choice of these times also allowed us to bin the data into
groups with reasonable sample sizes. Regardless of length of time since HIV-1 infection, the
CSF viral RNA concentration was less than 1,000 copies/ml in approximately two-thirds of
samples (Fig. 2A), suggestive of little local production of virus in the CNS, at least as assessed
by viral load. Analysis of the viral populations in the remaining samples showed that in approx-
imately 30% of the paired samples the sequence composition of the viral population in the CSF
was similar to the viral population in the blood (i.e. equilibrated), and pleocytosis was detected
in the CSF of one-quarter to one-half of the samples with these equilibrated populations
(Fig. 2A). Compartmentalized viral populations were also detected but exclusively after the
first 4 months, in 11% of samples in the early group (total n = 70) and 3% of the established
group (total n = 30). However, those samples in which pleocytosis was detected were signifi-
cantly less likely to have viral RNA levels in the CSF of less than 1,000 copies/ml compared to
the total group of samples (see below). The percentages of samples in each phylogenetic group
with pleocytosis (Fig. 2B) and without pleocytosis are noted (S1 Fig.).
We next assessed factors associated with the CSF viral load. We first examined subjects
without evidence of inflammation (i.e. no pleocytosis) and either low viral load in the CSF (less
than 1,000 copies/ml) or an equilibrated population as evidence of no sustained local replica-
tion. In these subjects the HIV-1 RNA concentration in the CSF was proportionally 1–2% of
the level in the blood (Spearman’s rank correlation coefficient = 0.48, P<0.0001) (Fig. 2C). We
could not determine whether this proportional relationship was maintained for those samples
in which the CSF viral load was undetectable (<50 copies/ml), although there was a trend for
these samples to be from subjects with low plasma HIV-1 RNA concentrations (Fig. 2C). We
hypothesize that this low level of virus in the CSF is due to the normal trafficking of T cells into
the CNS, including infected CD4+ T cells that release the observed virus.
Pleocytosis can be associated with elevated viral load in the CSF and an
influx of virus from the blood
Pleocytosis was detected in 36% of all subjects (Table 2 and S1). Consistent with our prior find-
ings in HIV-infected subjects, lymphocytes were the predominant cell type in subjects with
and without elevated levels of cellular inflammation [23]. When pleocytosis was detected, the
HIV-1 RNA concentration was twice as likely (64%) to be above 1,000 copies/ml in the CSF
compared to the overall population of which two-thirds were below 1,000 copies/ml. Addition-
ally, when pleocytosis was present and the CSF viral load was high enough for SGA analysis,
the viral populations were most often equilibrated (Fig. 2D, open circles), with a CSF viral load
that was significantly higher than for equilibrated populations without pleocytosis (P = 0.0008,
Mann-Whitney Test) (Fig. 2D). This suggests that the influx of infected CD4+ T cells associat-
ed with pleocytosis brings virus into the CSF/CNS from the blood. There was a trend toward
increased CSF:blood albumin ratio (a marker for reduced blood-brain barrier integrity) in the
presence of pleocytosis, which could contribute to an influx of virus (Table 2). However, there
was a similar (and statistically significant) increase in CSF:blood albumin ratio in the compart-
mentalized subjects that did not account for the increase in CSF HIV-1 RNA concentration
compared to the samples with equilibrated populations without pleocytosis (Fig. 2D; see
CNS HIV-1 Replication during Early Infection
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below), which was instead due to local virus production. These data suggest that increased viral
burden in the CNS can result from two factors: independent CNS replication, generating com-
partmentalized CSF populations, or an influx of infected cells as the result of the inflammatory
response of pleocytosis, producing a viral population in the CSF that is similar to that in the
blood. It is possible that much of the pleocytosis seen in these subjects is in response to HIV-1
replication in the CNS where the influx of infected cells from the blood produces elevated levels
of virus that obscure the detection of a lower level of the locally produced and
Fig 2. Correlates of CSF HIV-1 RNA levels, CNS inflammation, and CNS phylogenetic state. (A) Pie charts grouping the samples by days p.i. and
showing the percentage of samples in each phylogenetic state as a function of time: 0–4 months (‘acute’), 5–12 months (‘early’), and 13–24 (‘established’).
States represented include: Not Analyzed by SGA, due to CSF viral load<1,000 copies/ml; Equilibrated (−), CSFWBC<10 cells/μl; Equilibrated (+), CSF
WBC10 cells/μl; and Compartmentalized. We used a cut-off of 10 WBC/μl to define a state of substantial CSF pleocytosis because this is two-times the
upper limit of normal value of CSFWBC (0 to 5 cells/μl) [22] ensuring that the measured pleocytosis was a robust marker for an inflammatory response. (B)
Pie chart showing the percent of samples in each phylogenetic state exhibiting substantial CSF pleocytosis (CSFWBC10 cells/μl). (C) Relationship
between plasma and CSF HIV-1 RNA concentrations for not analyzed samples with minimal pleocytosis (NA (−); CSFWBC<10 cells/μl) and equilibrated
samples with minimal pleocytosis (Eq (−), CSFWBC<10 cells/μl). Spearman’s rank correlation coefficient and P-value are indicated. Samples with
undetectable CSF HIV-1 RNA (<50 copies/ml; limit of detection) were not included in the correlation analysis. (D) Relationship between CSF viral loads for
equilibrated with minimal pleocytosis (Eq (−); CSFWBC<10 cells/μl); equilibrated with marked pleocytosis (Eq (+); CSFWBC10 cells/μl); and
compartmentalized (Comp) samples. Significant P values (Mann-Whitney Test) comparing relationships between groups are indicated. Samples with
evidence of marked pleocytosis (CSFWBC10 cells/μl) are indicated using open circles, while samples with minimal to no pleocytosis are indicated by
solid circles.
doi:10.1371/journal.ppat.1004720.g002
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compartmentalized virus responsible for inducing the inflammation. Other agents that induce
pleocytosis should have a similar effect on viral load in the CSF and this was seen in an incident
of neurosyphilis in subject 9018 when sampled at day 687 p.i. (Table 2). However, we note that
pleocytosis is not always associated with higher viral load (Table 2 and S1), indicating a more
complex and perhaps dynamic relationship between pleocytosis and viral load.
Compartmentalized viral populations early are associated with higher
CSF viral loads, and local replication and/or inflammation can persist or
reoccur over time
Little evidence for local CNS replication was detected until after 4 months of infection
(Fig. 2A), suggesting that detectable CNS-compartmentalized populations are present at great-
er frequency with a longer time since HIV-1 exposure. As noted above, CSF samples with com-
partmentalized populations had elevated viral RNA loads when compared to the samples with
only equilibrated populations in the absence of pleocytosis (Fig. 2D), consistent with local pro-
duction of virus with the detection of compartmentalization.
We used cross sectional analyses to examine when these markers of local replication and in-
flammation were observed. We estimated the percentage of samples with no evidence of viral
involvement in the CNS from the number with a CSF viral RNA concentration less than 1,000
copies/ml (Fig. 2A; unanalyzed samples) and the number with equilibrated populations in
their CSF and little to no pleocytosis (Fig. 2A; equilibrated (−)). In contrast, we estimated the
percentage of samples with evidence of viral involvement in the CNS from the number with
equilibrated populations in their CSF and pleocytosis (Fig. 2A; equilibrated (+)) and the num-
ber with compartmentalized populations in their CSF (Fig. 2A; compartmentalized). In these
analyses we interpret equilibrated populations with pleocytosis/inflammation as an indirect
marker of local viral replication, i.e. the inflammatory response to local viral replication. Based
on these analyses we determined that the vast majority of samples collected during the three
time periods (0–4, 5–12 and 12–24 months p.i.) had no evidence of CNS involvement (82, 78
and 90%, respectively), while the remaining samples (18, 22 and 10%, respectively) had evi-
dence of CNS involvement. However, if viral replication and its associated markers (e.g. pleocy-
tosis) are transient or produce small signals, these values will underestimate the actual
proportion of subjects with viral replication in their CNS.
We used a longitudinal analysis to evaluate the persistence of viral replication in the CNS.
Of the 37 subjects with longitudinal sampling, the majority (17 of 37) had low CSF viral loads
at all sampling time points and were not analyzed by SGA (S1 Table). If we focus on the 20 sub-
jects that had higher CSF viral loads (>1,000 copies of HIV-1 RNA/ml) and were analyzed by
SGA, we observe that 9 (45%) had equilibrated populations with minimal to no pleocytosis at
all time points analyzed (Fig. 3A). The remaining 11 subjects (55% or 30% of all longitudinally
sampled subjects) all showed evidence of pleocytosis and/or compartmentalized viral replica-
tion at one or more time points within the initial two-year period (Fig. 3B) and 6 (30% or 16%
of all longitudinally sampled subjects) had one of these states at two or more time points
(Fig. 3B, subjects below dotted line). Thus, 55% of longitudinally sampled subjects analyzed by
SGA showed evidence of viral replication and/or marked pleocytosis in the CNS at one or
more time points, and 30% showed evidence of persistent viral replication in the CNS. Finally,
if the initial sample showed evidence of compartmentalization or an equilibrated population
with pleocytosis then subsequent samples were significantly more likely to also be compart-
mentalized or have pleocytosis than if the initial sample was not in one of these states (P =
0.001).
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Genetic evidence for the persistence of HIV-1 CNS replication
In two subjects, 9040 and 9021, a compartmentalized CNS population was observed at enroll-
ment and for all analyzed longitudinal time points, spanning a period of 753 and 201 days p.i.,
respectively (one time point beyond 2 years p.i. was analyzed for subject 9040 but was not
Fig 3. An assessment of the viral populations in the two compartments longitudinally. Examination of
longitudinal relationships early during infection for 20 subjects with multiple time points where at least one
time point was analyzed for viral populations. This group did not differ significantly from the 17 subjects with
longitudinal samples available but not analyzed (due to low CSF viral load) in the average number of samples
per person or the time span covered. Within individual subjects, the days post infection for each sample is
indicated using circles, which represent the following: open light blue circle, sample not analyzed due to CSF
viral load (VL)< 1,000 copies/ml (NA (low CSF VL)); open royal blue circle; sample not analyzed but CSF VL
> 1,000 copies/ml (NA (high CSF VL)); closed dark blue circle, equilibrated with minimal CSF pleocytosis
(CSFWBC<10 cells/μl) (Equilibrated (−)); closed pink circle, equilibrated with marked CSF pleocytosis (CSF
WBC10 cells/μl) (Equilibrated (+)); and closed red circle, compartmentalized. (A) Subjects with all analyzed
time points equilibrated with minimal to no pleocytosis and remaining time points not analyzed. (B) Subjects
with pleocytosis or compartmentalization in one time point (above dotted line) and subjects with pleocytosis,
or compartmentalization in at least two time points (below dotted line). In every subject the
compartmentalized (C) viral sequence population changed between sampling time points, indicated by
different subscript numbers.
doi:10.1371/journal.ppat.1004720.g003
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included in any overall population analysis). Further analysis of these subjects identified dis-
tinct trends of how HIV-1 becomes established in the CNS.
One pattern was seen in the viral evolution in subject 9040 (Fig. 4A). In this case a compart-
mentalized, clonally amplified population present at the initial time point (day 165) was re-
placed with a second compartmentalized, clonally amplified variant at day 352, but the
sampling included a recombinant between the first and second clonally amplified variants. Sev-
eral recombinants between these two early populations were maintained through day 918,
however, the overall population was equilibrated at this last time point. Using BEAST analysis
to estimate number of generations of the viral population, the time to most recent common an-
cestor (TMRCA) of the blood population at the initial time point was estimated to be 209 days,
reasonably consistent with the reported date of transmission (165 days prior to sampling). We
also estimated that the initial clonally amplified CSF population was established 33 days prior
to sampling (approximately 170 days after transmission), followed by a subsequent clonal am-
plification event and recombination between the two lineages. These data showed the early es-
tablishment of a lineage within the CNS that persisted over a period of at least 2 years. To our
knowledge, this was the first study to show the maintenance and evolution of a compartmental-
ized viral population within the CNS over a long duration of time starting during
early infection.
A second trend was seen for subject 9021 (Fig. 4B). Again, the reported date of transmission,
140 days prior to the first sampling date, was reasonably close to the transmission bottleneck
estimated using BEAST at 159 days prior to sampling. In this subject one compartmentalized,
clonally amplified lineage was detected in the CSF at the first sampling time point with an esti-
mated age of 102 days, or starting 57 days post infection. This lineage was not present at the
second sampling time point (at 341 days) but was replaced by a different compartmentalized,
Fig 4. Compartmentalization can persist and evolve independently within the CSF over time. Neighbor-joining phylogenetic trees showing how
compartmentalization can: (A) be persistent with multiple clonal expansions allowing recombination; (B) consist of sequential transient clonal expansions;
and (C) be established with a transmitted variant. env sequences from the CSF are labeled with circles (C, colors designated in figure) and env sequences
from the blood plasma are labeled with triangles (P, colors designated in figure). Days p.i. are noted. Bootstrap values 50 are indicated (*) at the
appropriate nodes to highlight the more significant branch points. Genetic distance is indicated at the top of each phylogenetic tree (0.001, number of
nucleotide substitutions per site between env sequences.) Compartmentalized populations are indicated at the appropriate node by an open circle and
emphasized using a blue bar. BEAST-generated TMRCAs of the entire viral population are noted adjacent to the subject ID, and the TMRCAs of the different
compartmentalized linages (subject 9040 and 9021) and transmitted parental lineages (subject 7146) are also noted.
doi:10.1371/journal.ppat.1004720.g004
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clonally amplified variant with an estimated age of 55 days. Thus for this subject we observed a
permissive environment for viral replication in which variants were successively and indepen-
dently amplified within the CNS.
Timing of introduction of HIV-1 into the CNS
We detected compartmentalization as early as 140 days p.i. (Table 2). Using BEAST to estimate
the time to most recent common ancestor (TMRCA) we were able to show that often these
CSF populations were established much earlier. Four subjects with longitudinal sampling (11
samples total) had a compartmentalized CSF population detected between 5–12 months post
infection (Table 2); three of these subjects had an initial clonally amplified CSF population
(7146, 9021 and 9040; Fig. 4). When we determined the estimated TMRCAs of these CSF pop-
ulations, we estimate the initial clonally amplified populations were all established within ap-
proximately the first four months after infection and two were established within the first two
months of infection (Table 2). These data show that the CNS compartment is permissive for
HIV-1 replication in at least a subset of subjects from very early times after infection.
We have recently shown that after vertical transmission to children, CNS compartmentali-
zation can be established early via the sequestration of one of multiple transmitted variants in
the CNS [14]. When we reanalyzed data from a previously described subject (7146, Fig. 4C) [4]
using BEAST, we showed that the phenomenon of transmission of two variants with one se-
questered in the CSF/CNS shortly after transmission also occurs in adults. In this case the two
transmitted variants diverged from each other in the donor (BEAST-estimated TMRCA of 965
days but with a reported transmission date of 156 days prior to sampling) while the transmitted
variants diversified in the recipient. One lineage that was present in both the blood and CSF
went through a bottleneck (presumably the transmission bottleneck) at 134 days prior to sam-
pling, again consistent with the reported transmission date of 156 days prior to sampling. The
other variant was sequestered in the CNS with an estimated bottleneck of 85 days, appearing
early as a clonally amplified variant. In addition, a series of recombinants between these two
lineages appeared in both the blood and CSF over time. This additional mechanism for estab-
lishing a compartmentalized viral population within the CNS early following transmission was
also observed for subject 9018 (Table 2).
All transmitted variants are R5 T cell-tropic and are predominantly
selected to use high levels of CD4 for entry
Macrophage-tropic HIV-1 variants can infect cells expressing low levels of CD4 while R5 T
cell-tropic viruses are selected for replication in cells with high levels of CD4 for entry [24–31].
Macrophage-tropic HIV-1 is seen most reliably as a compartmentalized CSF/CNS population
in a subset of individuals with HAD. To further our understanding of viral characteristics in
the CNS early during infection, we analyzed the entry phenotype of viruses isolated from our
adult primary infection cohort. Affinofile cells, on which CD4 and CCR5 surface expression can
be differentially induced [32], are a more reproducible model for entry tropism analysis com-
pared to primary cells [33]. We assessed entry phenotypes by measuring the ability of pseudo-
typed reporter viruses to enter Affinofile cells expressing either high or low levels of CD4.
Viruses pseudotyped with Env proteins derived from 24 subjects, representing all phyloge-
netic states and a wide range of days p.i., all required high levels of CCR5 and CD4 for efficient
entry and were considered R5 T cell-tropic (Fig. 5A-B). However, Env proteins from CSF sam-
ples containing compartmentalized viral lineages (all collected more than 4 months post infec-
tion) were significantly better at entering cells expressing low CD4 than Env proteins derived
from equilibrated CSF samples (ANOVA; P<<0.001). While this enhanced ability to enter low
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CD4 cells did not near the level of a macrophage-tropic Env protein (Fig. 5A-B, Ba-L), the
detectably elevated levels suggest that compartmentalized lineages may be adapting to enter
low CD4 cells in the CNS (discussed below). In contrast, viruses isolated from the CSF of adults
within four months of infection are uniformly poor at infecting low CD4 cells, indicating that
they have been selected for replication in T cells. This is consistent with multiple studies show-
ing that macrophage-tropic viruses are not transmitted [16,27,28,34–39]. Together these re-
sults indicate that the CNS is initially exposed to R5 T cell-tropic variants and that viruses in
the CNS remain R5 T cell-tropic for the first two years of infection, but the data provide sug-
gestive evidence that the evolution of macrophage tropism may begin during this period.
We also assessed the infectivity of a subset of the pseudotyped viruses on monocyte-derived
macrophages (MDMs) generated from three separate donors. Infectivity was first assessed on
Fig 5. All viruses required high levels of CD4 for efficient entry, indicative of primarily being selected for replication in CD4+ T cells. Single-cycle
infection of HIV-1 Env-pseudotyped reporter viruses on CD4lowCCR5high 293-Affinofile cells [28]. Receptor expression was measured as follows: CD4low =
972 receptors/cell, CD4high = 72,041 receptors/cell, CCR5high = 15,636 receptors/cell. The data are averaged from triplicate wells for each of 2 to 3 env clones
that were generated per indicated amplicon. Amplicons were selected for cloning to represent different portions of the phylogenetic tree. Subjects with no
evidence of CNS compartmentalization (i.e. equilibrated) are shown in panel (A); and subjects with CNS compartmentalization at one or more time points are
in panel (B). Longitudinal time points are indicated (T1, T2, T3, etc.) and samples with marked pleocytosis are noted (*).
doi:10.1371/journal.ppat.1004720.g005
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Affinofile cells expressing high levels of CD4, with equal levels of infectious virus then added to
each of the MDM preparations. There was general concordance between infectivity on Affino-
file cells and infectivity on MDMs, although the level of infectivity differed significantly be-
tween the three donors (S2 Fig.). Viruses representing subjects with equilibrated populations
and with low infectivity on Affinofile cells with low CD4 (Fig. 5A) had low infectivity on MDM
(from subjects 9027, 9045, 9055, 9063, and 9073; S2 Fig.).
Viruses from four of five subjects with CNS compartmentalization were also assessed for
their ability to enter Affinofile cells expressing low levels of CD4 and MDMs. Both blood- and
CSF-derived viruses from one subject (subject 9096) were observed to have intermediate infec-
tivity on low CD4 Affinofile cells (Fig. 5B) and MDMs (S2 Fig.). Similarly, two of the compart-
mentalized subjects (9018 and 9021) had CSF-derived viruses with elevated infectivity of low
CD4 Affinofile cells (Fig. 5B) and MDMs (S2 Fig.). Finally, both blood- and CSF-derived virus-
es from one compartmentalized subject (subject 7146) were unable to efficiently enter both low
CD4 expressing Affinofile cells and MDMs (S2 Fig.). Thus infectivity of MDMs is generally
consistent with the conclusions derived from infection of Affinofile cells although the variabili-
ty of infectivity of MDMs between donors precludes an accurate assessment of the range of
CD4 entry phenotypes that can be observed using Affinofile cells.
Discussion
Independent HIV-1 replication in the CNS has been associated with neurological disorders
[10,40,41] and may represent a distinct reservoir from that found in the blood and lymphoid
tissue [42,43]. We examined the virologic characteristics associated with early CNS infection
through analysis of paired cross-sectional and longitudinal blood plasma and CSF samples
from a large cohort of 72 ART-naïve subjects infected with HIV-1 for less than two years. Our
current study significantly builds upon a previous preliminary study by our group [4], enabling
us to propose a model with four distinct states to describe the relationship between viral popu-
lations in the CSF/CNS and viral populations within the peripheral blood during early HIV-1
infection. These states are based upon details revealed by the current study on mechanisms of
establishment of viral compartmentalization within the CNS, relationships between cellular in-
flammation, HIV-1 RNA levels and phylogenetic state, and insight into longitudinal mainte-
nance and evolution of compartmentalization.
The first state (Fig. 6A) was observed in subjects with little evidence of CNS replication or
pleocytosis, with CSF HIV-1 RNA concentrations proportionally 1–2% of the viral load in the
periphery (Fig. 2B). In many of these subjects, the CSF HIV-1 RNA level was very low, below
the limit of detection of standard assays. Minimal CSF viral burden has been observed in a
prior report on a portion of this primary infection cohort [5]. With little or no pleocytosis,
HIV-1 is likely entering the CSF/CNS at low levels via incomplete partitioning of virus at the
blood-brain barrier, or low level trafficking of immune cells, including small numbers of in-
fected CD4+ T cells. In this circumstance the viral population is very similar to the population
in the blood. It is possible that some HIV-1 is replicating independently in the CNS at low lev-
els in these subjects, but we were not able to detect these putative genetic variants above the
low level background of virus recently imported from the periphery into the CSF/CNS. An ar-
gument in favor of even this low level viremia in the CSF being the result of T cell trafficking is
the observation that in neuro-asymptomatic subjects with CD4+ T cells below 50 cells/ul in the
blood the viral load in the CSF is on average lower than in subjects with higher CD4+ T cell
counts [44,45].
In a second state (Fig. 6B), we observed a relationship between equilibrated viral popula-
tions with elevated viral load and high levels of pleocytosis (Fig. 2C). These equilibrated
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populations were most likely the result of the release of virus from increased numbers of in-
fected CD4+ T cells trafficking from the periphery into the CNS. Though pleocytosis of> 10
cells/ul might have been due to a variety of inflammatory conditions (e.g. neurosyphilis as doc-
umented in one individual), it is most likely in response to HIV-1 replication in these PHI sub-
jects. We screened for syphilis in this cohort, and detailed clinical and imaging assessment did
not reveal other contributing causes of pleocytosis. Furthermore, other ‘background’ non-HIV
causes of CSF WBC 10 cells/ul are unlikely in these subjects, as our parallel studies of 54
HIV-uninfected volunteers recruited from the similar local community demonstrated median
CSFWBC counts of 1 cell/ul (IQR 0–2), and none of these 54 subjects had a CSFWBC as high
as 10 [5]. In the setting of pleocytosis, while low levels of local CNS replication may have been
occurring, the virus imported from the periphery by infected CD4+ T cells dominated the pop-
ulation as it raised the CSF HIV-1 RNA concentration by release of virus imported from the
blood. If the inflammatory immune response was successful, pleocytosis might eventually re-
sult in low CSF viral loads, a condition observed in a small subset of subjects with pleocytosis
but very low levels of virus in the CSF (S1 Table). Pleocytosis was also observed in several sub-
jects with an intermediate viral population phenotype and half of the subjects with compart-
mentalized viral populations (Fig. 2D), suggesting pleocytosis may result in dynamic changes
in the viral population in the CSF. An association between equilibrated compartments and
high pleocytosis was also observed in a previous study analyzing four HIV-infected subjects
during therapy interruption [46].
Fig 6. Four states can define the relationship between virus in the CSF/CNS and blood early during infection. Blood and CSF/CNS compartments are
indicated. Blood plasma viral variants are represented by the red virus particles; and CNS viral variants are represented by the blue virus particles. CD4+ T
cells are represented by open circles. Arrows indicate direction of virus movement between compartments. (A) State with a CSF HIV-1 RNA level 1–2% of
the viral load in the blood and defined by minimal to no local CNS replication or inflammation, resulting in an equilibrated state between the two compartments
(when CSF viral load high enough for analysis). Transparent infected CD4+ T cell represents potential local CNS replication that may be obscured by the
import of virus into the CNS from the periphery. (B) State of equilibration between CSF and blood accompanied by high levels of pleocytosis, potentially
caused by local CNS replication. Transparent infected CD4+ T cell represents potential local CNS replication likely obscured by the high levels of virus
secreted by the infiltrating CD4+ T cells. (C) State of CSF/CNS clonal amplification of identical or nearly identical variants within CD4+ T cells. These clonally
amplified populations are characterized by low diversity, signified by all CSF viruses in a single shade of blue. (D) State of genetically complex,
compartmentalized viral replication within CD4+ T cells in the CSF/CNS indicative of persistent replication beyond a single clonal amplification event; this
complexity is signified by CNS viral variants in multiple shades of blue.
doi:10.1371/journal.ppat.1004720.g006
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In a third state (Fig. 6C), we observed clonally amplified CSF populations of low complexity
(Fig. 1 and 4) representing the recent expansion of identical or nearly identical variants that re-
quired high levels of CD4 for entry (R5 T cell-tropic; Fig. 5). High levels of pleocytosis were ob-
served in approximately half of the subjects with clonally amplified CSF populations, making it
possible that the influx of activated CD4+ T cells may also have provided cellular targets for
further transient amplification of a CSF variant. We [47] (Dukhovlinova et al., in preparation)
and others [48–50] have observed clonal amplification in the genital tract as well as in the CSF
both early [4,14] and at later times in infection [41]. Clonal amplification appears to be a dis-
tinct type of virus-host interaction where infection of a population of CD4+ T cells in a com-
partment is a low probability event and when it occurs there is transient rapid expansion of the
viral population. Due to the daily rapid turnover of the CSF viral RNA load, the elevated CSF
viral RNA load that is often observed during clonal amplification, and the fact that these clon-
ally amplified lineages generate their own diversity that can persist within the CNS, it is highly
unlikely that clonally amplified virus represents virus produced from a single cell. The detec-
tion of clonally amplified populations in the CSF within the first year of infection has allowed
us to estimate the establishment of these populations within the CNS to within the first 2–6
months (Table 2, Fig. 4), and such amplified populations were detected in 8% of subjects in this
study within the first year.
In the final state, we observed more genetically complex compartmentalized viral replication
within the CSF/CNS (Fig. 6D) indicative of persistent replication beyond a single clonal ampli-
fication event. In an effort to get a more complete view of the interaction of the virus within the
CNS at these early times of infection we have interpreted the presence of persistent replication
in the CNS based on four criteria: i) sequential clonal amplification events that indicated a per-
missive CNS environment for viral replication (Fig. 4B); ii) overlapping clonal amplification
events that gave rise to compartmentalized recombinants showing continuous replication be-
tween the sampled time points (Fig. 4A); iii) intermittent compartmentalization and pleocyto-
sis suggesting an inflammatory immune response to ongoing replication (Fig. 3B); and iv)
sequestration of a transmitted variant within the CNS (Fig. 4C). Collectively these markers de-
fined approximately 30% of subjects in the first two years as having evidence of viral replication
in the CNS in at least one time point, and 16% having evidence of replication and/or inflamma-
tion at multiple time points within this period. This suggests that the CNS compartment is per-
missive for HIV-1 replication in at least a subset of subjects from a very early period
after infection.
Entry tropism analysis revealed that all compartmentalized variants required high levels of
CD4 for entry. It is now widely described in the literature that macrophage-tropic variants uti-
lize low levels of CD4 for entry [24–31], are not transmitted, and that the transmitted virus is
R5 T cell-tropic [16,27,28,34–39], an understanding further supported by our phenotypic anal-
ysis (Fig. 5). Our finding that the viruses involved in this early persistent CNS replication were
adapted to replication in CD4+ T cells is distinct from previous studies of individuals with
HAD where genetically complex compartmentalized CSF populations that had been replicating
as an isolated population had evolved to replicate in macrophages/microglia [41]. Thus, adap-
tation to use low levels of CD4 for entry, a hallmark of macrophage tropism, is not a feature of
the transmitted virus and does not evolve during the early stages of CNS infection in adults, at
least as reflected in the compartmentalized virus detected in the CSF. However, we do note that
the compartmentalized viruses from the CSF show a small but statistically significant increase
in the ability to enter cells with low levels of CD4 compared to CSF virus from equilibrated sub-
jects (Fig. 5B). One explanation for this small difference is that the virus in the CNS is carrying
out at least a portion of its replication in a cell with low levels of CD4 which allows for at least a
low level of selection for a low CD4 entry phenotype. We found no consistent differences in
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glycosylation site count or positions, or consistent sequence changes in sites previously de-
scribed as being associated with macrophage tropism in comparing the viral sequences from
the plasma to the compartmentalized sequences in the CSF (S2 Table and S3).
The only CNS tissue that is readily sampled in volunteer human subjects is CSF, which,
though not identical to brain, is produced within the brain in the choroid plexus, and reflects
brain inflammation and infection in the context of CNS infections including HIV-1. Measures
of immune activation, HIV-1 burden, and neural injury detected in CSF are markers of brain
involvement in HIV-1 that correlate to clinical and pathologic disease [51]. While the cellular
source of HIV-1 RNA detected in the CSF is not certain and may differ during different stages
of infection [52], compartmentalization of HIV-1 detected in CSF associates with clinical de-
mentia in humans [10] and immunopathology in the brain in rhesus macaques [53]. Despite
limitations of generalizing CSF findings to those of the CNS more broadly, our studies have
used the best methods available in living humans to assess HIV-1 populations derived from the
CNS in a unique cohort of subjects enrolled during primary HIV-1 infection. Our results show
that in cross-sectional analysis over the first two years of HIV-1 infection, 30% of subjects have
evidence of either local viral replication in the CNS or a robust CNS inflammatory response,
and that in approximately 16% of subjects this CNS involvement can persist over time. We
have found that the viral population in the CSF is dynamic as the result of local replication
and/or the influx of virus in infected CD4+ T cells as part of an inflammatory response. This
early viral replication in a subset of subjects may represent an inability to protect the CNS from
infection, potentially leading to HAND later in infection, and may also define a distinct reser-
voir of infected cells within the body. Longitudinal follow-up of these subjects to examine the
long-term impact of the presence of early active HIV-1 replication in the CNS will help to de-
fine the significance of these findings for clinical neurologic disease outcomes and compart-
mentalized viral reservoirs in the setting of HIV-1.
Materials and Methods
Ethics statement
The study was approved by the Institutional Review Boards at UCSF, Yale University, and the
University of North Carolina at Chapel Hill. All study participants were adults (age 18
years). Written informed consent was obtained from all participants.
Study design
We assessed samples obtained through an observational longitudinal neurological study of pri-
mary HIV-1 infection to determine viral characteristics associated with early HIV-1 CNS infec-
tion. Subjects were referred from the community and were eligible if they met prospectively
determined criteria for laboratory confirmation of primary HIV-1 infection, as previously de-
scribed [4]. Subjects were screened at study enrollment for systemic syphilis by blood RPR test-
ing. Subsequent blood and CSF samples were tested for RPR and VDRL, respectively, if an
outside test suggested syphilis exposure or CSFWBC was markedly elevated compared to that
in an earlier longitudinal sample. No subjects had clinical evidence of other inflammatory neu-
rologic disorders such as multiple sclerosis or CNS opportunistic infections based on interview
and examination by an HIV-1 neurologist at each visit. A total of 57 of the 72 subjects volun-
teered to participate in magnetic resonance imaging of the brain for the overall study protocol;
scans were reviewed by a neuroradiologist and none revealed evidence of encephalitis, tumor
or opportunistic infection. Blood and CSF samples were collected at enrollment, six weeks, and
every six months thereafter. This analysis included samples obtained up to two years post-in-
fection from subjects enrolled prior to 4/1/2012. CSF and plasma HIV-1 RNA concentrations
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were determined as described [4]; paired samples were selected for further SGA analysis if CSF
HIV-1 RNA was greater than1,000 copies/ml (to ensure adequate sampling). Samples with
lower viral loads could be analyzed if larger volumes were committed to concentrate the virus,
but we chose to use a cut-off of 1,000 viral RNA copies/ml for these studies. Primary study end-
points included SGA of the HIV-1 env gene for viral genetic compartmentalization and pheno-
typic analyses, CSF and blood HIV-1 RNA concentrations, measures of CSF cellular
inflammatory response (white blood count, WBC) and blood brain barrier disruption (CSF:
plasma albumin ratio).
Single genome amplification
When collected, CSF samples were initially placed on wet ice and delivered to the lab for pro-
cessing within one hour. For virology analyses, CSF samples were centrifuged at 1200 x g for
10 min to remove contaminating cells or cellular debris, and the supernatant was subsequently
aliquoted and stored at −70°C for later assay. Viral RNA was isolated as previously described
from the CSF supernatant [4]. Briefly, RNA was isolated from samples (140 μl) with viral loads
>10,000 copies/ml using the QIAmp Viral RNAMini kit (Qiagen). To increase template num-
ber, samples with viral loads<10,000 copies/ml were first pelleted by ultracentrifugation.
cDNA was generated using an oligo-d(T) primer. Single genome amplification/template end-
point dilution PCR [38] of the env gene through the 3’ LTR U3 end was conducted using the
cDNA as template as previously described [4,14]. Sequences for full-length env were generated
(samples analyzed previously were sequenced from the start of V1 through the ectodomain of
gp41 [4]).
Phylogenetic analysis of env viral sequences
Phylogenetic analysis were conducted in a manner similar to our previous study [14]. In brief,
DNA sequences were aligned (MUSCLE) [54–56] using EBI web tools [57], and phylogenetic
trees were generated (neighbor-joining method, MEGA 4.0 [58]). Phylogenetic states were de-
termined by statistical evaluation using the Slatkin-Maddison (SM) test [18] as previously de-
scribed [14], Wright’s measure of population subdivision (Fst) [19,20] and the Nearest-
neighbor statistic (Snn) [21]. CSF populations were defined as being compartmentalization if
all three statistical tests (SM, Fst and Snn) yielded significant results (P values< 0.05) or equili-
brated if one or more of tests yielded non-significant results. Low bootstrap values were used
(35) because of the overall low diversity of the viral populations early after infection. Clonally
amplified lineages (short branch lengths with bootstrap values 99 and a clade of 3 vari-
ants) were also identified. No contamination occurred between samples (S3 Fig.). Sequences
for subjects 9002 (338 d.p.i.), 9007, 9018 (200 d.p.i.), 9025, 9037, 9039, 9040 (165 d.p.i.), and
7146 were generated in our previous study [4].
Bayesian analysis
A Bayesian Markov Chain Monte Carlo (MCMC) approach using BEAST v.1.6.1 [15] estimat-
ed the TMRCA for each viral population. A substitution rate of 1.5x10−5 substitutions/site/gen-
eration and standard deviation of 3.0x10−6 were fixed under a lognormal relaxed clock
(uncorrelated) model. The rate was calculated via tip dating, using a consensus sequence (set as
day 0), and the estimated days post infection. The HKY nucleotide substitution model had esti-
mated base frequencies and a gamma-distributed rate heterogeneity (4 gamma categories). A
coalescent Bayesian Skyline tree prior with a Piecewise-constant skyline model was used (10
groups). The MCMC algorithm was run for 30 million generations, logging every 1000 and
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with a 10% burn-in. The results from at least two independent runs were combined, and the ef-
fective sample size for all estimates was>200. A generation time of 1.0 day was used.
Construction of HIV-1 env clones
Full length HIV-1 env genes were re-amplified from the first-round SGA products as previous-
ly described [41]. The PCR product was cloned into the pcDNA3.1D/V5-His-TOPO expres-
sion vector (Invitrogen) using the pcDNA 3.1 directional TOPO expression kit (Invitrogen).
Cells
293T cells were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and 100 mg/ml of penicillin and streptomycin. 293-Affinofile
cells [32], generously provided by Dr. Ben-Hur Lee, were maintained in DMEM supplemented
with 10% dialyzed FBS (12–14 kD dialyzed; Atlanta Biologicals) and 50 mg/ml blasticidin
(D10F/B).
Env-pseudotyped viruses
Env-pseudotyped luciferase reporter viruses were generated as previously described [14]. Brief-
ly, 293T cells were cotransfected with an env expression vector and the pNL4-3.LucR-E- HIV-1
backbone (obtained from the NIH AIDS Research and Reference Reagent Program, Division
of AIDS, NIAID, NIH) using the Fugene 6 transfection reagent and protocol (Roche). Trans-
fection medium was replaced with fresh culture medium five hours post-transfection and the
cells were incubated at 37°C for 48 hours, after which viral supernatants were filtered with
0.45 μM filters (Millipore) and stored at −80°C.
293-Affinofile cellular surface expression of CD4 and CCR5
293-Affinofile cell [32] CD4 and CCR5 receptor expression was induced with doxycycline
(doxy; Invitrogen) and ponasterone A (ponA; Invitrogen), respectively, as previously described
[14]. Briefly, cells were induced at two conditions: CD4high/CCR5high (6 ng/ml doxy and 5 μM
ponA, respectively) and CD4low/CCR5high (0 ng/ml doxy and 5 μM ponA). CD4 and CCR5 re-
ceptor expression was measured using quantitative fluorescence-activated cytometry (qFACS)
following staining with either phycoerythin (PE)-conjugated anti-human CD4 antibody (clone
Q4120, BD Biosciences) or PE-conjugated mouse anti-human CCR5 antibody (clone 2D7, BD
Biosciences), and surface levels were calculated using QuantiBRITE beads (BD Biosciences).
Single-cycle infection of 293-Affinofile cells
As described previously [14], Env-pseudotyped luciferase reporter viruses were first titered
on 293-Affinofile cells [32] expressing CD4high/CCR5high. For viral infections, black tissue cul-
ture plates (96 wells) were coated with 10% poly-L-lysine and seeded with 293-Affinofile cells
(1.85 x 104 cells/well). Eighteen to 24 hours later, expression of CD4 and CCR5 was induced at
CD4high/CCR5high and CD4low/CCR5high. Eighteen to 24 hours later, the induction medium
was removed and replaced with 100 μl of fresh, warmed culture medium containing Env-pseu-
dotyped virus. The plates were spinoculated [59] at 2,000 rpm for 2 hours at 37°C, and incubat-
ed for 48 hours at 37°C. Infection medium was removed, cells were lysed, and luciferase
activity was assayed using the luciferase assay system (Promega). Clone sequences were not
compared to the original parental sequence prior to pseudotyping and Affinofile cell infection.
Instead, entry tropism data for each parental amplicon included three replicates from 2–3
clones derived from the same parental amplicon. In this analysis we assume any PCR-
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introduced error would either not change the entry phenotype or would create a nonfunctional
protein which would not be included in the subsequent analysis. The concordance of the entry
phenotype of the replicate clones was taken to represent the phenotype of the
amplicon sequence.
Statistical analysis
Compartmentalization was assessed statistically using the Slatkin-Maddison test for gene flow
[18], Wright’s measure of population subdivision (Fst) [19,20] and the Nearest-neighbor statis-
tic (Snn) [21]. Differences between groups were examined for statistical significance using the
Mann-Whitney Test. The one exception was our analysis examining whether env genes derived
from samples with and without CSF compartmentalized lineages differed in their ability to
enter Affinofile cells expressing low levels of CD4 expression. We used a linear model to per-
form this analysis (performed in [R]) and used the stepAIC function to perform stepwise
model selection. All correlations employed Spearman’s rank correlation coefficient. For all sta-
tistical tests, P values less than 0.05 were considered significant.
Nucleotide sequence accession numbers
The HIV-1 env nucleotide sequences determined in this study have been deposited in GenBank
under accession numbers KM353586-KM355197
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S1 Fig. Samples in each phylogenetic group without pleocytosis. Pie chart showing the per-
cent of samples in each phylogenetic state exhibiting minimal to no CSF pleocytosis (CSF
WBC<10 cells/μl). States represented include: Not Analyzed by SGA, due to CSF viral load
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were infected with two positive controls that are known to be macophage-tropic (4051_C3 [41]
and Ba-L [60]), two negative controls that are known to be T cell-tropic (4051_P8 [41] and
JRCSF [61]) and pairs of pseudoviruses from nine subjects described in this study. Each pair
was comprised of a CSF-derived virus (“C” clone) and a plasma-derived virus (“P” clone). Each
virus was used to infect three replicate wells of cells from donors 1 and 3 and two replicate
wells from donor 2. MDMs were generated and infected using the protocol described in Joseph
et al. [62]. Briefly, monocytes were isolated from the blood of three healthy donors and differ-
entiated for seven days in medium containing recombinant human macrophage colony stimu-
lating factor (M-CSF). MDMs were then infected with the volume of each pseudovirus stock
that we previously determined to generate 800,000 relative light units (RLU) of luciferase ex-
pression when used to infect maximally induced Affinofile cells. Five days after infection,
MDMs were lysed and luciferase expression was measured. The y-axis shows the mean RLUs
from replicate wells.
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S3 Fig. No contamination was observed between subjects. Neighbor-joining phylogenetic
tree (radial topology). env sequences from the CSF are labeled with solid blue circles and env
sequences from the blood plasma are labeled with solid red triangles. Genetic distance is indi-
cated at the bottom of the figure (0.001) and indicates the number of nucleotide substitutions
per site between env sequences. Each subject ID and corresponding sampling time point
CNS HIV-1 Replication during Early Infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1004720 March 26, 2015 20 / 24
are indicated.
(TIFF)
S1 Table. Virologic and clinical characteristics for subjects not analyzed by SGA.
(DOCX)
S2 Table. Env glycosylation site analysis of compartmentalized subjects.
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